Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Education » Book Chapters » Focus on Sickle Cell Research Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Central Asia: Perspectives and Present Challenges
$144.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Bestsellers
01.Sickle Cell Hemoglobinopathy And Sudden Death (pp. 125-130)
02.Stroke In Sickle Cell Anemia In The Mid-Southern Region Of Turkey (pp. 59-67)
Notifications more
NotificationsNotify me of updates to Stroke In Sickle Cell Disease (pp. 69-80)
Tell A Friend
 
Tell someone you know about this product.
Stroke In Sickle Cell Disease (pp. 69-80) $25.00
Authors:  Arshad, Jawad A.; Klausner, Howard A.; Lewandowski, Christopher (Henry Ford Hospital, Detroit, MI)
Abstract:
Stroke in sickle cell disease (SCD) is the leading cause of cerebrovascular accident in children, and is the leading cause of death in sickle cell patients. SCD is caused by the substitution of a valine for a glutamate in the hemoglobin. This leads to rigidity of the hemoglobin and it precipitates readily during hypoxemia. SCD affects both small and large blood vessels. The sludging of the red blood cells causes reactive changes to blood vessels leading to intimal hyperplasia. The Cooperative Study of Sickle Cell Disease has reported four risk factors for stroke in sickle cell patients: i) previous transient ischemic attack, ii) low steady state hemoglobin, iii) frequent/recent acute chest syndrome, and iv) elevated systolic blood pressure. Other risk factors are genetic, environmental, and infectious. Stroke in sickle cell disease is usually “silent,” and so most cerebrovascular accidents are not clinically apparent. Young children with SCD are especially at risk for stroke, and require close neuropsychological testing to monitor their performance. Transcranial Doppler is a useful modality that compares well with MRI to assess for stroke. The mainstay of therapy is preventive. In acute presentations of stroke, the standard antiplatelet therapy including thrombolytics can be used. Hydroxyurea and a routine transfusion regimen is used for prevention of stroke in SCD. 


Available Options:
Version:
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Stroke In Sickle Cell Disease (pp. 69-80)